Drug Database
Back to search

France· FR:61068966

CARTIFIT 200 mg/250 mg, gélule

A medicinal product containing chlorhydrate de glucosamine + sulfate de chondroïtine, registered in France by LABORATORIO REIG JOFRE (ESPAGNE).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCARTIFIT 200 mg/250 mg, géluleATC—REGISTER NO.FR:61068966PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhydrate de glucosamine + sulfate de chondroïtineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE GLUCOSAMINE + SULFATE DE CHONDROÏTINE
Manufacturer
LABORATORIO REIG JOFRE (ESPAGNE)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930119655
    plaquette(s) PVC PVDC aluminium de 90 gélule(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chlorhydrate de glucosamine + sulfate de chondroïtine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorhydrate de glucosamine + sulfate de chondroïtine products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Austria · Cartifit
  • Spain · Droglican
  • Finland · Droglican
  • Hungary · Droglycan
  • Poland · Chronada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6ba3f91b-1cec-4a17-abea-564e7662dc1a
GET /v1/drugs/6ba3f91b-1cec-4a17-abea-564e7662dc1a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61068966",
  "date_amm": "2017-10-18",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE GLUCOSAMINE + SULFATE DE CHONDROÏTINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about chlorhydrate de glucosamine + sulfate de chondroïtine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console